Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of $0.24, $0.05 better than the analyst estimate of $0.19. Revenue for the quarter came in at $106.51 million versus the consensus estimate of $92.11 million.

GUIDANCE:

Ironwood Pharma sees FY2026 revenue of $450-475 million, versus the consensus of $458.6 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.